Related Experiment Video
Updated: May 21, 2026

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714
Andrea Pozo-Rodrigálvarez1, Ana Gradillas, Julia Serrano
1Neurovascular Research Group, Department of Molecular, Cellular and Developmental Neurobiology, Instituto Cajal (CSIC), Av. Doctor Arce 37, 28002 Madrid, Spain.
Abstract:
In an experimental permanent stroke model, we report here the contribution of ONO-1714 to brain damage prevention. Daily drug administration, twenty-one days prior to and two days after an experimental infarct, was performed by using mini-osmotic pumps (ALZET). Infarct volumes were assessed by image analysis of sequential coronal brain 1 mm(3) sections stained following the 2,3,5-triphenyltetrazolium chloride histological staining technique. Results of this study provide evidence of a significant reduction of the brain lesion size, suggesting ONO-1714 as a potential neuroprotective agent in stroke patients. ONO-1714 was prepared in our laboratory following a procedure which resulted in the supply of the desired compound in an easy and excellent yield.
Insights
The experimental drug ONO-1714 significantly reduced brain damage in a stroke model. This suggests ONO-1714 may be a promising neuroprotective agent for stroke patients.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Stroke is a leading cause of death and disability.
- Developing effective neuroprotective agents is crucial for stroke treatment.
Purpose of the Study:
- To investigate the neuroprotective effects of ONO-1714 in an experimental stroke model.
- To assess the potential of ONO-1714 as a therapeutic agent for stroke patients.
Main Methods:
- An experimental permanent stroke model was utilized.
- ONO-1714 was administered daily for 23 days using mini-osmotic pumps.
- Infarct volumes were quantified using 2,3,5-triphenyltetrazolium chloride staining and image analysis.
Main Results:
- A significant reduction in brain lesion size was observed in the ONO-1714 treated group.
- The drug was successfully synthesized in the laboratory with good yield.
Conclusions:
- ONO-1714 demonstrated significant neuroprotective effects in a preclinical stroke model.
- These findings support the potential of ONO-1714 as a novel neuroprotective therapy for stroke.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Neurogenesis and Regeneration of Nervous Tissue
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Hemorrhagic Stroke ll: Pathophysiology

